pmid,title,journal,year,drug,disease
40383127,"Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.",The Lancet. Infectious diseases,2025,Molnupiravir,Parkinson's
